Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

This multicenter open-label extension study conducted in France is designed to provide ATH434 orally BID to eligible patients who completed the Phase 2 study ATH434-201, and who may benefit from this treatment according to the evaluation by the Investigator.

Participants needed: 5
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Alterity TherapeuticsUpdated: Jul 28, 2026Locations: 4
Eligibility criteria

Completed Alterity protocol ATH434-201. [+1]

Discontinued prior ATH434 treatment (ATH434-201) for any reason. [+1]

Status: Available

Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

This multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.

Trial details
Biological sex: AllType: Expanded AccessSponsor: Alterity TherapeuticsUpdated: Apr 15, 2026
Eligibility criteria

Completed Alterity protocol ATH434-201 or ATH434-202 [+1]

Discontinued prior ATH434 treatment (ATH434-201 or ATH434-202) for any reason [+1]